Please provide your email address to receive an email when new articles are posted on . “Prior research has established the subcutaneous ICD as a reasonable alternative to the transvenous ICD in ...
Patients with intracardiac shunts might at some point require a pacemaker or an implantable cardioverter–defibrillator (ICD). These patients may have numerous thrombotic risk factors, however, and ...
One of the largest and longest follow-ups of patients implanted with the subcutaneous-lead implantable cardioverter defibrillator (S-ICD), now marketed as the EMBLEM S-ICD (Boston Scientific), paints ...
Please provide your email address to receive an email when new articles are posted on . Five-year data show sustained safety and efficacy outcomes after implantation of a transvenous phrenic nerve ...
The US Food and Drug Administration has approved the Aurora Extravascular Implantable Cardioverter Defibrillator (EV-ICD; Medtronic) along with its Epsila EV defibrillation lead as an alternative to ...